Richard A Murphy1, Luba Nisenbaum2,3, Amy S Labar4, Robert L Sheridan5, Jean-Baptiste Ronat2, Kelly Dilworth2, Jade Pena2, Erin Kilborn2, Carrie Teicher4. 1. Division of Infectious Diseases, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, 1000 W. Carson St, Box 466, Torrance, CA, 90509, USA. ramurphy@gmail.com. 2. Médecins Sans Frontières/Doctors Without Borders, 8, Rue Saint Sabin, 75011, Paris, France. 3. Rowan University School of Osteopathic Medicine, One Medical Center Drive, Stratford, NJ, 08084-1501, USA. 4. Epicentre, 55 Rue Crozatier, Paris, France. 5. Division of Burns, Massachusetts General Hospital, 55 Blossom St., Boston, MA, 02114, USA.
Abstract
BACKGROUND: Compare to high-income settings, survival in burn units in low-income settings is lower with invasive infections one leading cause of death. Médecins Sans Frontières is involved in the treatment of large burns in adults and children in Haiti. METHODS: In 2014, we performed a review of 228 patients admitted consecutively with burn injury during a 6-month period to determine patient outcomes and infectious complications. Microbiology was available through a linkage with a Haitian organization. Regression analysis was performed to determine covariates associated with bloodstream infection and mortality. RESULTS: 102 (45 %) patients were male, the median age was 8 years (IQR, 2-28), and the majority of patients (60 %) were admitted to the unit within 6 h of injury. There were 20 patients (9 %) with culture-proven bacteremia. Among organisms in blood, common isolates were Staphylococcus aureus (42 %), Pseudomonas aeruginosa (23 %), and Acinetobacter baumannii (15 %). Among patients with burns involving <40 % total body area, 4 (2 %) of 192 died and 20 (65 %) of 31 with ≥40 % body surface area involvement died. Factors associated with mortality included involvement of ≥40 % of body surface, depth, and flame as the mechanism. Multidrug-resistant infections were common; 18 % of S. aureus isolates were methicillin resistant, and 83 % of P. aeruginosa isolates were imipenem resistant. CONCLUSIONS: A low mortality rate was observed in a humanitarian burn surgery project in patients with burns involving <40 % of total body surface. Invasive infection was common and alarming rates of antibiotic resistance were observed, including infections not treatable with antibiotics available locally.
BACKGROUND: Compare to high-income settings, survival in burn units in low-income settings is lower with invasive infections one leading cause of death. Médecins Sans Frontières is involved in the treatment of large burns in adults and children in Haiti. METHODS: In 2014, we performed a review of 228 patients admitted consecutively with burn injury during a 6-month period to determine patient outcomes and infectious complications. Microbiology was available through a linkage with a Haitian organization. Regression analysis was performed to determine covariates associated with bloodstream infection and mortality. RESULTS: 102 (45 %) patients were male, the median age was 8 years (IQR, 2-28), and the majority of patients (60 %) were admitted to the unit within 6 h of injury. There were 20 patients (9 %) with culture-proven bacteremia. Among organisms in blood, common isolates were Staphylococcus aureus (42 %), Pseudomonas aeruginosa (23 %), and Acinetobacter baumannii (15 %). Among patients with burns involving <40 % total body area, 4 (2 %) of 192 died and 20 (65 %) of 31 with ≥40 % body surface area involvement died. Factors associated with mortality included involvement of ≥40 % of body surface, depth, and flame as the mechanism. Multidrug-resistant infections were common; 18 % of S. aureus isolates were methicillin resistant, and 83 % of P. aeruginosa isolates were imipenem resistant. CONCLUSIONS: A low mortality rate was observed in a humanitarian burn surgery project in patients with burns involving <40 % of total body surface. Invasive infection was common and alarming rates of antibiotic resistance were observed, including infections not treatable with antibiotics available locally.
Authors: Patricia M Schmidt; Robert L Sheridan; Christina L Moore; Steve C Scuba; Booker T King; Paul M Morrissey; Leopoldo C Cancio Journal: J Burn Care Res Date: 2014 Sep-Oct Impact factor: 1.845
Authors: Carmen Peña; Gabriel Cabot; Silvia Gómez-Zorrilla; Laura Zamorano; Alain Ocampo-Sosa; Javier Murillas; Benito Almirante; Virginia Pomar; Manuela Aguilar; Ana Granados; Esther Calbo; Jesús Rodríguez-Baño; Fernando Rodríguez-López; Fe Tubau; Luis Martínez-Martínez; Antonio Oliver Journal: Clin Infect Dis Date: 2014-11-06 Impact factor: 9.079
Authors: David G Greenhalgh; Jeffrey R Saffle; James H Holmes; Richard L Gamelli; Tina L Palmieri; Jureta W Horton; Ronald G Tompkins; Daniel L Traber; David W Mozingo; Edwin A Deitch; Cleon W Goodwin; David N Herndon; James J Gallagher; Art P Sanford; James C Jeng; David H Ahrenholz; Alice N Neely; Michael S O'Mara; Steven E Wolf; Gary F Purdue; Warren L Garner; Charles J Yowler; Barbara A Latenser Journal: J Burn Care Res Date: 2007 Nov-Dec Impact factor: 1.845
Authors: Anna F Tyson; Laura P Boschini; Michelle M Kiser; Jonathan C Samuel; Steven N Mjuweni; Bruce A Cairns; Anthony G Charles Journal: Burns Date: 2013-06-13 Impact factor: 2.744
Authors: Jean-Baptiste Ronat; Jabar Kakol; Marwan N Khoury; Mathilde Berthelot; Oliver Yun; Vincent Brown; Richard A Murphy Journal: PLoS One Date: 2014-08-11 Impact factor: 3.240